Enantioselectivity of human AMP, dTMP and UMP-CMP kinases

Nucleic Acids Research

Volumn 35, Issue 14, 2007, Pages 4895-4904

  Alexandre, Julie A C ^a   Roy, Beatrice ^b   Topalis, Dimitri ^a   Pochet, Sylvie ^c   Périgaud, Christian ^b   Deville Bonne, Dominique ^a  

^a SORBONNE UNIVERSITÉ   (France)

^b UNIVERSITÉ DE MONTPELLIER   (France)

^c INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE PHOSPHATE; ADENYLATE KINASE; BETA 2' AZIDO 2' DEOXYCYTIDINE 5' MONOPHOSPHATE; BETA 2' AZIDO 2' DEOXYURIDINE 5' MONOPHOSPHATE; BETA 2' DEOXYADENOSINE 5' MONOPHOSPHATE; BETA 2' DEOXYCYTIDINE 5' MONOPHOSPHATE; BETA 2' DEOXYTHYMIDINE 5' MONOPHOSPHATE; BETA 2' DEOXYURIDINE 5' MONOPHOSPHATE; BETA ADENOSINE 5' MONOPHOSPHATE; CYTIDINE PHOSPHATE; DEOXYADENOSINE PHOSPHATE; DEOXYCYTIDINE PHOSPHATE; DEOXYRIBONUCLEOSIDE; DEOXYURIDINE PHOSPHATE; DOCKING PROTEIN; LAMIVUDINE; NUCLEAR MATRIX PROTEIN; NUCLEOSIDE ANALOG; NUCLEOSIDE MONOPHOSPHATE KINASE; PROTEIN KINASE; RIBONUCLEOTIDE; THYMIDINE PHOSPHATE; UNCLASSIFIED DRUG; URIDINE PHOSPHATE;

ARTICLE; BINDING AFFINITY; ENANTIOMER; ENANTIOSELECTIVITY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE; FLUORESCENCE ANALYSIS; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR DOCKING; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; STEREOSPECIFICITY; STRUCTURE ANALYSIS;

ADENYLATE KINASE; BINDING SITES; DEOXYRIBONUCLEOTIDES; HUMANS; ISOENZYMES; NUCLEOSIDE-PHOSPHATE KINASE; PHOSPHORYLATION; PYRIMIDINE NUCLEOTIDES; RECOMBINANT PROTEINS; STEREOISOMERISM; SUBSTRATE SPECIFICITY;

EID: 34547885006     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkm479     Document Type: Article

References (49)

1. Nair,V. and Jahnke,T.S. (1995) Antiviral activities of isometric dideoxynucleosides of D- and L-related stereochemistry. Antimicrob. Agents Chemother., 39, 1017-1029.
2. Zemlicka,J. (2000) Enantioselectivity of the antiviral effects of nucleoside analogues. Pharmacol. Ther., 85, 251-266.
3. Cheng,Y.C. (2001) Potential use of antiviral L(-)nucleoside analogues for the prevention or treatment of viral associated cancers. Cancer Lett., 162(Suppl.), S33-S37.
4. Mathe,C. and Gosselin,G. (2006) L-Nucleoside enantiomers as antivirals drugs: A mini-review. Antiviral Res., 71, 276-281.
5. Jurovcik,M. and Holy,A. (1976) Metabolism of pyrimidine L-nucleosides. Nucleic Acids Res., 3, 2143-2154.
6. Bryant,M.L., Bridges,E.G., Placidi,L., Faraj,A., Loi,A.G., Pierra,C., Dukhan,D., Gosselin,G., Imbach,J.L. et al. (2001) Antiviral L-nucleosides specific for hepatitis B virus infection. Antimicrob. Agents Chemother., 45, 229-235.
7. Maury,G. (2000) The enantioselectivity of enzymes involved in current antiviral therapy using nucleoside analogues: A new strategy? Antivir. Chem. Chemother., 11, 165-189.
8. Munch-Petersen,B., Cloos,L., Tyrsted,G. and Eriksson,S. (1991) Diverging substrate specificity of pure human thymidine kinases 1 and 2 against antiviral dideoxynucleosides. J. Biol. Chem., 266, 9032-9038.
9. Wang,J., Choudhury,D., Chattopadhyaya,J. and Eriksson,S. (1999) Stereoisomeric selectivity of human deoxyribonucleoside kinases. Biochemistry, 38, 16993-16999.
10. Verri,A., Priori,G., Spadari,S., Tondelli,L. and Focher,F. (1997) Relaxed enantioselectivity of human mitochondrial thymidine kinase and chemotherapeutic uses of L-nucleoside analogues. Biochem. J., 328(Pt 1), 317-320.
11. Shafiee,M., Griffon,J.F., Gosselin,G., Cambi,A., Vincenzetti,S., Vita,A., Eriksson,S., Imbach,J.L. and Maury,G. (1998) A comparison of the enantioselectivities of human deoxycytidine kinase and human cytidine deaminase. Biochem. Pharmacol., 56, 1237-1242.
12. Van Rompay,A.R., Johansson,M. and Karlsson,A. (2003) Substrate specificity and phosphorylation of antiviral and anticancer nucleoside analogues by human deoxyribonucleoside kinases and ribonucleoside kinases. Pharmacol. Ther., 100, 119-139.
13. Yan,H. and Tsai,M.D. (1999) Nucleoside monophosphate kinases: Structure, mechanism, and substrate specificity. Adv. Enzymol. Relat. Areas Mol. Biol., 73, 103-134.
14. Liou,J.Y., Dutschman,G.E., Lam,W., Jiang,Z. and Cheng,Y.C. (2002) Characterization of human UMP/CMP kinase and its phosphorylation of D- and L-form deoxycytidine analogue monophosphates. Cancer Res., 62, 1624-1631.
15. Pasti,C., Gallois-Montbrun,S., Munier-Lehmann,H., Veron,M., Gilles,A.M. and Deville-Bonne,D. (2003) Reaction of human UMP-CMP kinase with natural and analog substrates. Eur. J. Biochem., 270, 1784-1790.
16. Kreimeyer,A., Schneider,B., Sarfati,R., Faraj,A., Sommadossi,J.P., Veron,M. and Deville-Bonne,D. (2001) NDP kinase reactivity towards 3TC nucleotides. Antiviral Res., 50, 147-156.
17. Krishnan,P., Liou,J.Y. and Cheng,Y.C. (2002) Phosphorylation of pyrimidine L-deoxynucleoside analog diphosphates. Kinetics of phosphorylation and dephosphorylation of nucleoside analog diphosphates and triphosphates by 3-phosphoglycerate kinase. J. Biol. Chem., 277, 31593-31600.
18. Gallois-Montbrun,S., Faraj,A., Seclaman,E., Sommadossi,J.P., Deville-Bonne,D. and Veron,M. (2004) Broad specificity of human phosphoglycerate kinase for antiviral nucleoside analogs. Biochem. Pharmacol., 68, 1749-1756.
19. Cihlar,T. and Chen,M.S. (1996) Identification of enzymes catalyzing two-step phosphorylation of cidofovir and the effect of cytomegalovirus infection on their activities in host oells. Mol. Pharmacol., 50, 1502-1510.
20. Feng,J.Y. and Anderson,K.S. (1999) Mechanistic studies comparing the incorporation of (+) and (-) isomers of 3TCTP by HIV-1 reverse transcriptase. Biochemistry, 38, 55-63.
21. Feng,J.Y., Murakami,E., Zorca,S.M., Johnson,A.A., Johnson,K.A., Schinazi,R.F., Furman,P.A. and Anderson,K.S. (2004) Relationship between antiviral activity and host toxicity: Comparison of the incorporation efficiencies of 2′,3′-dideoxy-5-fluoro-3′-thiacytidine- triphosphate analogs by human immunodeficiency virus type 1 reverse transcriptase and human mitochondrial DNA polymerase. Antimicrob. Agents Chemother., 48, 1300-1306.
22. Liou,J.Y., Krishnan,P., Hsieh,C.C., Dutschman,G.E. and Cheng,Y.C. (2003) Assessment of the effect of phosphorylated metabolites of anti-human immunodeficiency virus and anti-hepatitis B virus pyrimidine analogs on the behavior of human deoxycytidylate deaminase. Mol. Pharmacol., 63, 105-110.
23. Mazzon,C., Rampazzo,C., Scaini,M.C., Gallinaro,L., Karlsson,A., Meier,C., Balzarini,J., Reichard,P. and Bianchi,V. (2003) Cytosolic and mitochondrial deoxyribonucleotidases: Activity with substrate analogs, inhibitors and implications for therapy. Biochem. Pharmacol., 66, 471-479.
24. Thelander,L. and Larsson,B. (1976) Active site of ribonucleoside diphosphate reductase from Escherichia coli. Inactivation of the enzyme by 2′-substituted ribonucleoside diphosphates. J. Biol. Chem., 251, 1398-1405.
25. Salowe,S., Bollinger,J.M.Jr, Ator,M., Stubbe,J., McCraken,J., Peisach,J., Samano,M.C. and Robins,M.J. (1993) Alternative model for mechanism-based inhibition of Escherichia coli ribonucleotide reductase by 2′-azido-2′-deoxyuridine 5′-diphosphate. Biochemistry, 32, 12749-12760.
26. Roy,B., Verri,A., Lossani,A., Spadari,S., Focher,F., Aubertin,A.M., Gosselin,G., Mathe,C. and Perigaud,C. (2004) Enantioselectivity of ribonucleotide reductase: A first study using stereoisomers of pyrimidine 2′-azido-2′-deoxynucleosides. Biochem. Pharmacol., 68, 711-718.
27. He,J., Roy,B., Perigaud,C., Kashlan,O.B. and Cooperman,B.S. (2005) The enantioselectivities of the active and allosteric sites of mammalian ribonucleotide reductase. FEBS J., 272, 1236-1242.
28. Topalis,D., Collinet,B., Gasse,C., Dugue,L., Balzarini,J., Pochet,S. and Deville-Bonne,D. (2005) Substrate specificity of vaccinia virus thymidylate kinase. FEBS J., 272, 6254-6265.
29. Yoshikawa,M., Kato,T. and Takenishi,T. (1967) A novel method for phosphorylation of nucleosides to 5′-nucleotides. Tetrahedron Lett. 50, 5065-5068.
30. Xing,J., Apedo,A., Tymiak,A. and Zhao,N. (2004) Liquid chromatographic analysis of nucleosides and their mono-, di- and triphosphates using porous graphitic carbon stationary phase coupled with electrospray mass spectrometry. Rapid Commun. Mass Spectrom., 18, 1599-1606.
31. Pochet,S., Dugue,L., Labesse,G., Delepierre,M. and Munier-Lehmann,H. (2003) Comparative study of purine and pyrimidine nucleoside analogues acting on the thymidylate kinases of Mycobacterium tuberculosis and of humans. Chembiochem, 4, 742-747.
32. Blondin,C., Serina,L., Wiesmuller,L., Gilles,A.M. and Barzu,O. (1994) Improved spectrophotometric assay of nucleoside monophosphate kinase activity using the pyruvate kinase/lactate dehydrogenase coupling system. Anal. Biochem., 220, 219-221.
33. Chen,Y., Gallois-Montbrun,S., Schneider,B., Veron,M., Morera,S., Deville-Bonne,D. and Janin,J. (2003) Nucleotide binding to nucleoside diphosphate kinases: X-ray structure of human NDPK-A in complex with ADP and comparison to protein kinases. J. Mol. Biol., 332, 915-926.
34. DeLano,W. (2002) The PyMOL Molecular Graphics System. DeLano Scientific, Palo Alto, CA, USA.
35. Thompson,M. (2004) ArgusLab edn. Planaria Software LLC, Seattle, WA.
36. Noma,J., Fujisawa,K., Yamashiro,Y., Shinohara,M., Nakazawa,A., Gondo,T., Ishihara,J. and Yoshinobu,K. (2001) Structure and expression of human mitochondrial adenylate kinase targeted to the mitochondrial matrix. Biochem. J., 358, 225-232.
37. Ren,H., Wang,L., Bennett,M., Liang,Y., Zheng,X., Lu,F., Li,L., Nan,J, Luo,M. et al. (2005) The crystal structure of human adenylate kinase 6: An adenylate kinase localized to the cell nucleus. Proc. Natl Acad. Sci. USA, 102, 303-308.
38. Arima,T., Akiyoshi,H. and Fujii,S. (1977) Characterization of pyrimidine nucleoside monophosphokinase in normal and malignant tissues. Cancer Res., 37, 1593-1597.
39. Schulz,G.E., Schiltz,E., Tomaselli,A.G., Frank,R., Brune,M., Wittinghofer,A. and Schirmer,R.H. (1986) Structural relationships in the adenylate kinase family. FEBS J., 161, 127-132.
40. Vonrheim,C., Schlauderer,G.J. and Schulz,G.E. (1995) Movie of the structural changes during a catalytic cycle of nucleoside monophosphate kinases. Structure, 3, 483-490.
41. Filippakopoulos,P., Bunkoczi,G., Jansson,A., Schreurs,A., Knapp,S., Edwards,A., Von Delft,F. and Sundstrom.M. (2005) Crystal structure of human AK1A in complex with AP5A. Structural Genomics Consortium Oxford, PDB code 1Z83.
42. Ostermann,N., Segura-Pena,D., Meier,C., Veit,T., Monnerjahn,C., Konrad,M. and Lavie,A. (2003) Structures of human thymidylate kinase in complex with prodrugs: Implications for the structure-based design of novel compounds. Biochemistry, 42, 2568-2577.
43. Segura-Pena,D., Sekulic,N., Ort,S., Konrad,M. and Lavie,A. (2004) Substrate-induced conformational changes in human UMP/CMP kinase. J. Biol. Chem., 279, 33882-33889.
44. Scheffzek,K., Kliche,W., Wiesmuller,L. and Reinstein,J. (1996) Crystal structure of the complex of UMP/CMP kinase from Dictyostelium discoideum and the bisubstrate inhibitor P1-(5′-adenosyl) P5-(5′-uridyl) pentaphosphate (UP5A) and Mg2 + at 2.2A: Implications for water-mediated specificity. Biochemistry, 35, 9716-9727.
45. Wolf-Watz,M., Thai,V., Henzler-Wildman,K., Hadjipavlou,G., Eisenmesser,E.Z. and Kern,D. (2004) Linkage between dynamics and catalysis in a thermophilic-mesophilic enzyme pair. Nat. Struct. Mol. Biol., 11, 945-949.
46. Bae,E. and Phillips,G.N.Jr (2006) Roles of static and dynamic domains in stability and catalysis of adenylate kinase. Proc. Natl. Acad. Sci. USA, 103, 2132-2137.
47. Hu,R., Li,L., Degreve,B., Dutschman,G.E., Lam,W. and Cheng,Y.C. (2005) Behavior of thymidylate kinase toward monophosphate metabolites and its role in the metabolism of 1-(2′-deoxy-2′-fluoro-beta-L-arabinofuranosyl)-5-methyluracil (Clevudine) and 2′,3′-didehydro-2′,3′-dideoxythymidine in cells. Antimicrob. Agents Chemother., 49, 2044-2049.
48. Hernandez-Santiago,B., Placidi,L., Cretton-Scott,E., Faraj,A., Bridges,E.G., Bryant,M.L., Rodriguez-Orengo,J., Imbach,J.L., Gosselin,G. et al. (2002) Pharmacology of beta-L-thymidine and beta-L-2′-deoxycytidine in HepG2 cells and primary human hepatocytes: relevance to chemotherapeutic efficacy against hepatitis B virus. Antimicrob. Agents Chemother., 46, 1728-1733.
49. Sabini,E., Hazra,S., Konrad,M., Burley,S.K. and Lavie,A. (2007) Structural basis for activation of the therapeutic L-nucleoside analogs 3TC and troxacitabine by human deoxycytidine kinase. Nucleic Acids Res., 35, 186-192.